Clinical trials in Hodgkin lymphoma

The list below shows The Lymphoma Group's current clinical trials open for recruitment for Hodgkin lymphoma patients.

• RADAR – testing brentuximab vedotin, combined with chemotherapy, in people with stage 1A or 2A Hodgkin lymphoma who haven’t had treatment before
• SGN35C-001 – a phase 1 trial of SGN-35C in patients with relapsed or refractory lymphoma
• PRIMAVERA – phase 1 / 2 trial testing AZD3470 in patients with relapsed or refractory Hodgkin lymphoma

With special thanks to the following:

For further information on each trial, please visit the Find a trial page on Lymphoma Action’s website.